WELLS FARGO & COMPANY/MN - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 273 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$10,951,034
-64.5%
286,752
-61.7%
0.00%
-66.7%
Q2 2023$30,816,679
-50.3%
749,251
-30.7%
0.01%
-50.0%
Q1 2023$62,029,150
+13.8%
1,080,459
+11.2%
0.02%
+12.5%
Q4 2022$54,493,087
+75.7%
971,876
+32.7%
0.02%
+60.0%
Q3 2022$31,012,000
-39.2%
732,131
-22.4%
0.01%
-37.5%
Q2 2022$50,975,000
-28.7%
943,457
-15.2%
0.02%
-11.1%
Q1 2022$71,462,000
-1.8%
1,112,083
+2.3%
0.02%0.0%
Q4 2021$72,803,000
-6.7%
1,086,782
-4.6%
0.02%
+5.9%
Q3 2021$78,012,000
+12.6%
1,139,188
+12.2%
0.02%
+13.3%
Q2 2021$69,257,000
+9.7%
1,014,897
+11.0%
0.02%
+7.1%
Q1 2021$63,149,000
+14.4%
914,015
+7.5%
0.01%
+7.7%
Q4 2020$55,197,000
+53.3%
850,233
+11.5%
0.01%
+30.0%
Q3 2020$36,016,000
-5.6%
762,741
-6.0%
0.01%
-9.1%
Q2 2020$38,149,000
-1.0%
811,848
-6.1%
0.01%
-15.4%
Q1 2020$38,551,000
+204.2%
864,631
+297.6%
0.01%
+333.3%
Q4 2019$12,674,000
-1.4%
217,474
+1.7%
0.00%
-25.0%
Q3 2019$12,849,000
+7.2%
213,901
-0.4%
0.00%
+33.3%
Q2 2019$11,990,000
-3.9%
214,681
-4.1%
0.00%
-25.0%
Q1 2019$12,472,000
+34.0%
223,833
+8.5%
0.00%
+33.3%
Q4 2018$9,308,000
-33.1%
206,376
-2.3%
0.00%
-25.0%
Q3 2018$13,920,000
-71.2%
211,326
-71.8%
0.00%
-71.4%
Q2 2018$48,322,000
+3.8%
750,232
-10.8%
0.01%0.0%
Q1 2018$46,555,000
+11.9%
841,260
-3.3%
0.01%
+16.7%
Q4 2017$41,616,000
+2.2%
869,537
+7.8%
0.01%
-7.7%
Q3 2017$40,704,000
-44.4%
806,333
-40.0%
0.01%
-45.8%
Q2 2017$73,231,000
-29.6%
1,343,459
-45.6%
0.02%
-29.4%
Q1 2017$103,972,000
-42.1%
2,467,892
+18.0%
0.03%
-46.0%
Q4 2016$179,475,000
+18.8%
2,092,035
+14.3%
0.06%
+12.5%
Q3 2016$151,043,000
+14.6%
1,829,718
+10.7%
0.06%
+9.8%
Q2 2016$131,815,000
+21.9%
1,652,225
+2.9%
0.05%
+18.6%
Q1 2016$108,159,000
+9.6%
1,605,715
+10.3%
0.04%
+10.3%
Q4 2015$98,684,000
+106.5%
1,455,929
+81.5%
0.04%
+95.0%
Q3 2015$47,780,000
-10.0%
802,346
+1.8%
0.02%0.0%
Q2 2015$53,088,000
-56.4%
788,022
-60.1%
0.02%
-16.7%
Q1 2015$121,684,000
+115.7%
1,973,774
+89.7%
0.02%
+9.1%
Q4 2014$56,416,000
+8.5%
1,040,305
-0.7%
0.02%0.0%
Q3 2014$51,988,000
-13.2%
1,047,299
-17.7%
0.02%
-12.0%
Q2 2014$59,904,000
+6.0%
1,272,949
+3.6%
0.02%
+4.2%
Q1 2014$56,530,000
+1.7%
1,229,189
+5.5%
0.02%0.0%
Q4 2013$55,572,000
+413.5%
1,164,779
+333.2%
0.02%
+380.0%
Q3 2013$10,823,000
+51.9%
268,905
+38.3%
0.01%
+25.0%
Q2 2013$7,124,000194,4730.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q1 2022
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders